Zydus inks pact with Pharm Aid for vaccine technology
September 19, 2017 Business Line Cadila Healthcare Ltd (Zydus Cadila) on Tuesday informed that the company has entered into an exclusive agreement with Russian company Pharm Aid Ltd for the technology knowhow on varicella vaccine production in the Russian Federation. Through this agreement, Zydus gains access to the public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakhstan, Armenia and Kyrgyzstan. Cadila Healthcare stock was trading 0.18 per cent down at Rs 485.65 on the BSE. "We welcome this opportunity to participate in and partner biotech opportunities in the Russian Federation market. As an innovation-driven global healthcare player, our aim has always been to bridge unmet healthcare needs by improving accessibility to preventives and novel therapies," said Sharvil Patel, Managing Director, Zydus Cadila. The exclusive agreement was signed at the 'Biotechmed' conference in Gelendzhik, Russia. Pharm Aid Ltd has been set u...